Biological Information
Background Information:
Rsk2, also known as Ribosomal Protein S6 Kinase A3, is a member of the RSK family of serine/threonine kinases. This kinase contains 2 non-identical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) Signaling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Mutations in this gene have been associated with Coffin-Lowry syndrome (CLS). The protein sequence is identical to that described in GenBank NM_004586 for human RSK2, over residues 2–end. The cDNA however is more closely related to the mouse sequence described in GenBank AY083469.
Target Class:
Kinase
Family:
AGC
Sub Family:
Protein Ser/Thr
Protein Name:
RSK2
Protein Aliases:
90 kDa ribosomal protein S6 kinase 3|p90-RSK 3|p90RSK3|Insulin-stimulated protein kinase 1|ISPK-1|MAP kinase-activated protein kinase 1b|MAPK-activated protein kinase 1b|MAPKAP kinase 1b|MAPKAPK-1b|Ribosomal S6 kinase 2|RSK-2|pp90RSK2
Accession Number:
NM_004586.2
UniProt Number:
P51812
Gene Name:
RPS6KA3
Gene ID:
6197
Gene Aliases:
RSK|RSK2|HU-3|ISPK1|MAPKAPK1B
Target Species:
Human
Usage
Product Type:
Enzymes
Application:
Drug Discovery & Development
Storage Conditions:
1 year at -70°C
Usage disclaimer:
These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.
Assay Information
Assay Type:
Enzymatic
Bioassay Data
Trademark Statement:
For Research Use Only
Clinical Relevance
Therapeutic Area:
Oncology/Immuno-Oncology